Servier Extends Its Drug Discovery Chemistry Collaboration With Tripos

ST. LOUIS & BUDE, England--(BUSINESS WIRE)--July 31, 2006--Tripos, Inc. (Nasdaq:TRPS - News), a leading provider of drug discovery chemistry and informatics products and services, and Servier, the largest independent French pharmaceutical company, today announced that they have extended their drug discovery collaboration to identify potential obesity drugs.

MORE ON THIS TOPIC